Literature DB >> 15910992

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.

D N Wedlock1, M A Skinner, G W de Lisle, H M Vordermeier, R G Hewinson, R Hecker, S van Drunen Littel-van den Hurk, L A Babiuk, B M Buddle.   

Abstract

Culture filtrate protein (CFP) vaccines have been shown to be effective in small animal models for protecting against tuberculosis while immunisation with these types of vaccines in cattle has been less successful. A study was conducted in cattle to evaluate the ability of selected adjuvants and immunomodulators to stimulate protective immune responses to tuberculosis in animals vaccinated with Mycobacterium bovis CFP. Seven groups of cattle (n=5) were vaccinated with M. bovis CFP formulated with either Emulsigen or Polygen adjuvant alone or in combination with a specific oligodeoxynucleotides (ODN), polyinosinic acid: polycytidylic acid (poly I:C) or poly I:C and recombinant granulocyte-macrophage colony stimulating factor. Two additional groups were vaccinated subcutaneously with BCG or non-vaccinated. In contrast to the strong interferon-gamma (IFN-gamma) responses induced by BCG, the CFP vaccines induced strong antibody responses but weak IFN-gamma responses. The addition of CpG ODN to CFP significantly enhanced cell-mediated responses and elevated antibody responses to mycobacterial antigens. Of the CFP vaccinated groups, the strongest IFN-gamma responses to CFP vaccines were measured in animals vaccinated with CFP/Emulsigen+CpG or CFP/Polygen+CpG. The animals in these two groups, together with those in the BCG and non-vaccinated groups were challenged intratracheally with virulent M. bovis at 13 weeks after the first vaccination and protection was assessed, by examination for presence of tuberculous lesions in the lungs and lymph nodes, 13 weeks later at postmortem. While BCG gave the best overall protection against tuberculosis, significant protection was also seen in animals vaccinated with CFP/Emulsigen+CpG. These results establish an important role for CpG ODN in stimulating protective Th1 responses to tuberculosis in cattle and indicate that a sub-unit protein vaccine can protect these animals against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910992     DOI: 10.1016/j.vetimm.2005.01.002

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.

Authors:  D Neil Wedlock; Michel Denis; Margot A Skinner; Jessica Koach; Geoffrey W de Lisle; H Martin Vordermeier; R Glyn Hewinson; Sylvia van Drunen Littel-van den Hurk; Lorne A Babiuk; Rolf Hecker; Bryce M Buddle
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Is interleukin-4delta3 splice variant expression in bovine tuberculosis a marker of protective immunity?

Authors:  Shelley G Rhodes; Jason Sawyer; Adam O Whelan; Gillian S Dean; Michael Coad; Katie J Ewer; Andreas S Waldvogel; Anthony Zakher; Derek J Clifford; R Glyn Hewinson; H Martin Vordermeier
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

3.  Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.

Authors:  D Neil Wedlock; Michel Denis; Gavin F Painter; Gary D Ainge; H Martin Vordermeier; R Glyn Hewinson; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

4.  Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.

Authors:  Sylvie Bertholet; Gregory C Ireton; Maria Kahn; Jeffrey Guderian; Raodoh Mohamath; Nicole Stride; Elsa M Laughlin; Susan L Baldwin; Thomas S Vedvick; Rhea N Coler; Steven G Reed
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

5.  Assessment of bovine mammary chemokine gene expression in response to lipopolysaccharide, lipotechoic acid + peptidoglycan, and CpG oligodeoxynucleotide 2135.

Authors:  Jeremy A Mount; Niel A Karrow; Jeff L Caswell; Herman J Boermans; Ken E Leslie
Journal:  Can J Vet Res       Date:  2009-01       Impact factor: 1.310

6.  Mesenteric lymph node cells from neonates present a prominent IL-12 response to CpG oligodeoxynucleotide via an IL-15 feedback loop of amplification.

Authors:  Stéphanie Ferret-Bernard; Sonia Lacroix-Lamandé; Aude Remot; Coralie Metton; Nelly Bernardet; Bernard Charley; Françoise Drouet; Fabrice Laurent
Journal:  Vet Res       Date:  2011-02-02       Impact factor: 3.683

7.  Intramuscular administration of a synthetic CpG-oligodeoxynucleotide modulates functional responses of neutrophils of neonatal foals.

Authors:  Noah D Cohen; Jessica R Bourquin; Angela I Bordin; Kyle R Kuskie; Courtney N Brake; Kaytee B Weaver; Mei Liu; M Julia B Felippe; Michael H Kogut
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.